Sienna Biopharmaceuticals, Inc. Share Price Other OTC
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Sales 2017 | - | Sales 2018 | - | Capitalization | 48.12M 4.01B |
---|---|---|---|---|---|
Net income 2017 | -50M -4.17B | Net income 2018 | -73M -6.09B | EV / Sales 2017 | - |
Net cash position 2017 | 74.47M 6.21B | Net cash position 2018 | 18.4M 1.53B | EV / Sales 2018 | - |
P/E ratio 2017 |
-3.5
x | P/E ratio 2018 |
-0.65
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 99.54% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 27/10/27 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 01/16/01 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 01/16/01 |
Founder | 59 | 27/10/27 |
1st Jan change | Capi. | |
---|---|---|
-1.86% | 104B | |
+6.78% | 97.47B | |
+5.71% | 22.25B | |
-12.89% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.25% | 16.36B | |
+6.51% | 14.39B | |
+35.21% | 12.37B |